A detailed history of Alpha Centric Advisors LLC transactions in Enovis Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 27,500 shares of ENOV stock, worth $1.21 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
27,500
Previous 20,000 37.5%
Holding current value
$1.21 Million
Previous $904,000 30.86%
% of portfolio
1.0%
Previous 0.75%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$40.57 - $48.1 $304,275 - $360,750
7,500 Added 37.5%
27,500 $1.18 Million
Q2 2024

Jul 25, 2024

BUY
$44.56 - $62.43 $891,200 - $1.25 Million
20,000 New
20,000 $904,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.